Avanos Medical Balance Sheet Health
Financial Health criteria checks 6/6
Avanos Medical has a total shareholder equity of $1.2B and total debt of $176.6M, which brings its debt-to-equity ratio to 14.4%. Its total assets and total liabilities are $1.7B and $433.4M respectively. Avanos Medical's EBIT is $59.3M making its interest coverage ratio 5.1. It has cash and short-term investments of $75.8M.
Key information
14.4%
Debt to equity ratio
US$176.60m
Debt
| Interest coverage ratio | 5.1x |
| Cash | US$75.80m |
| Equity | US$1.23b |
| Total liabilities | US$433.40m |
| Total assets | US$1.66b |
Recent financial health updates
Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05
We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt
Sep 10We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt
Jun 09Recent updates
Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S
Apr 17Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates
Aug 14When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
Aug 13Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy
Jul 16We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing
May 18Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital
May 07Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Avanos Medical Q4 2022 Earnings Preview
Feb 20Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate
Feb 10Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching
Jan 13Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance
Nov 02Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate
Sep 12Avanos Medical Q2 2022 Earnings Preview
Aug 08When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
May 28Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?
Feb 10Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?
Dec 21An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued
Nov 04Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt
Sep 10The Strong Earnings Posted By Avanos Medical (NYSE:AVNS) Are A Good Indication Of The Strength Of The Business
Aug 10Is There Now An Opportunity In Avanos Medical, Inc. (NYSE:AVNS)?
Jun 30We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt
Jun 09Avanos Medical Q1 2021 Earnings Preview
May 06Financial Position Analysis
Short Term Liabilities: AVNS's short term assets ($467.8M) exceed its short term liabilities ($205.2M).
Long Term Liabilities: AVNS's short term assets ($467.8M) exceed its long term liabilities ($228.2M).
Debt to Equity History and Analysis
Debt Level: AVNS's net debt to equity ratio (8.2%) is considered satisfactory.
Reducing Debt: AVNS's debt to equity ratio has reduced from 19.4% to 14.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable AVNS has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: AVNS is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 44.2% per year.